AI assistant
CANN GROUP LIMITED — Board/Management Information 2022
Oct 2, 2022
64603_rns_2022-10-02_3692f6e3-ae3a-4065-9c43-f4da04e0a00d.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [109 x 42] intentionally omitted <==
ASX ANNOUNCEMENT
3 October 2022
Resignation and appointment of Company Secretary
3 October 2022 – Cann Group Limited (ASX: CAN) ( Cann or the Company ) announced today that Ms Geraldine Farrell has resigned as Company Secretary effective 25 October 2022, after the Company’s Annual General Meeting has concluded on that date.
Cann also announced that Ms Deborah Ambrosini, the Company’s Chief Financial Officer ( CFO ), will be appointed as Company Secretary following Ms Farrell’s departure.
Ms Ambrosini was appointed as CFO of Cann on 1 September 2022. In addition to her experience as a CFO in senior finance roles with ASX-listed companies, Ms Ambrosini brings significant experience as a company secretary, most recently as CFO and Company Secretary with Acrux Limited (ASX:ACR).
Authorised for release by the Board of Directors, Cann Group Limited.
For all media enquiries please contact:
Rhys Cohen Senior Corporate Communications Manager +61 449 679 095 [email protected]
For all other information please contact:
Peter Crock Deborah Ambrosini CEO CFO Cann Group Limited Cann Group Limited +61 3 9095 7088 +61 3 9095 7088 [email protected] [email protected]
About Cann Group
Cann Group Limited (ABN 25 603 949 739) is enhancing patients’ lives by developing, producing, and supplying innovative cannabis medicines. The Company has built world-class research, cultivation and GMP manufacturing facilities in Melbourne, and a state-of-the-art large-scale cultivation and GMP manufacturing facility near Mildura, Victoria. Cann Group supplies a range of dried flower and oil products, as well as active pharmaceutical ingredients and extracts, to customers in Australia and around the world. Cann Group also owns Satipharm and its patent-protected capsule technology. Learn more at: www.canngrouplimited.com | www.satipharm.com
Cann Group Limited (ACN 603 949 739) Ground Floor, 262-276 Lorimer Street, Port Melbourne VIC 3207 Australia Ph: +61 3 9095 7088